UnitedHealth Group (UNH) reported fourth-quarter earnings that exceeded analyst expectations, the company said in a Jan. 27 press release, but forecast a decline in 2026 revenue as Medicare Advantage pressures persist. Cost controls under CEO Stephen Hemsley are expected to keep adjusted profit slightly above estimates.

UnitedHealth reported consolidated 2025 revenue of $447.6 billion, a 12% increase from the prior year. The company recorded a $1.6 billion restructuring charge in the fourth quarter related to its financial turnaround, which reduced quarterly profit to $10 million.

The quarter modestly beat analyst consensus, which had projected earnings per share between $2.10 and $2.12 and revenue near $113.6 billion to $113.8 billion.

2026 Outlook and Medicare Advantage Rates

UnitedHealth’s guidance projects a decline in 2026 revenue, citing finalized Medicare Advantage payment growth of 5.06% for the year. The Trump administration described the rate as disappointing, a factor the company said weighed on its top line.

The company expects adjusted 2026 profit to come in slightly above analyst estimates, supported by medical cost controls overseen by Hemsley. UnitedHealth said a stronger finish to 2025 provided momentum for its turnaround efforts.

Elevance Health Wednesday reported fourth quarter net income of $547 million as healthcare cost issues continued to drag earnings of the health insurance giant.

Elevance Health Reports $547 Million Profit Despite Rising Costs

Elevance Health forecast 2026 profit below Wall Street expectations on Wednesday, as the health insurer expects higher medical costs to persist into the year.

Elevance forecasts 2026 profit below estimates on elevated medical costs

UnitedHealth Group (NYSE: UNH) announced its Q4 2025 earnings yesterday, which slightly fell short on revenue ($113.2B compared to the expected $113.7B) while meeting EPS forecasts at $2.11. However, the main issue?

UNH Stock: Why Did The Healthcare Giant Stumble?

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As we enter 2026, our focus is on advancing affordability and making healthcare easier to access and navigate for the members we serve. Through pricing discipline and targeted investments, we are strengthening the earnings power of our diversified.

Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

Expand NYSE: UNH UnitedHealth Group Today's Change (-19.61%) $-68.94 Current Price $282.70 Key Data Points Market Cap $319B Day's Range $280.40 - $299.50 52wk Range $234.60 - $606.36 Volume 66M Avg Vol 7.5M Dividend Yield 2.48% UnitedHealth Group (UNH 19.61%), a major provider of health insurance and healtchare services, closed Tuesday at $282.69, down 19.61%. The stock sold off after  Q4 results showed plunging operational earnings, hefty restructuring charges, and weaker‑than‑expected 2026 revenue guidance.

Stock Market Today, Jan. 27: UnitedHealth Group Plunges Almost 20% After Weak Earnings

UnitedHealth Group's Optum health services business is working on its own turnaround that includes leaving some markets and ending contracts with medical care providers that aren't aligned with the company's strategy.

For UnitedHealth's Optum, It's ‘Back To Basics' With Smaller Footprint

In this video, I will cover UnitedHealth Group's (UNH 19.74%) recent quarterly results and explain why the stock tanked. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Is UnitedHealth Stock a No-Brainer Buy Again Under $300?

UnitedHealth Group Incorporated remains a contrarian Buy after a sharp selloff, with recent Medicare Advantage rate news pressuring margins and investor sentiment. UNH expects 2026 revenues to decline 2%, but operating income should exceed $24B, reflecting successful cost controls and AI-driven efficiency gains. Despite near-term EPS growth of just 8.6%, management targets a long-term adjusted EPS CAGR of 13–16%, suggesting significant re-rating potential at a forward P/E of 15.8.

UnitedHealth Group: Recovery Might Take Longer, But Contrarians Know What To Do

UnitedHealth Group Inc (NYSE:UNH) stock is eyeing its worst single-day percentage loss since April, last seen down 19.8% to trade at $281.96.

UnitedHealth Stock on Track for Worst Day Since April

UnitedHealth Group Incorporated is facing a sharp selloff due to a surprise Medicare Advantage rate proposal and disappointing FY26 guidance. UNH's rising medical care ratio, now at 88.9%, signals margin compression and structural cost headwinds that threaten near-term profitability. Optum remains a strategic bright spot, but its outperformance cannot fully offset mounting insurance business pressures and sector-wide regulatory risks.

UnitedHealth Group Stock Is Not Attractive Yet: Caution Is Warranted

UnitedHealth experienced a 20% single-day drop, but I view this as a major overreaction given its strong fundamentals. UNH's 2026 guidance signals a shift from growth to margin recovery, with adjusted EPS targeted at $17.75+ and operating margin at 5.5%. Management is exiting unprofitable Medicaid states and focusing on higher-margin business, accepting a 2% revenue decline for improved profitability.

UnitedHealth Group: I Might Add On This Massive Overreaction

Universal Health Services (UHS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Universal Health Services (UHS) Beat Estimates Again in Its Next Earnings Report?

UNH tops Q4 EPS estimates as Optum Rx drove growth, but profits plunged year over year, and management set a cautious 2026 outlook amid rising costs.

UnitedHealth Q4 Earnings Beat on Strong Optum Rx, Offers 2026 Outlook

U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs

The health insurer's stock fell by almost 20%.

UnitedHealth Is Pummeling the Dow. The Rest of the Market Is Fine.

Health insurance company UnitedHealth Group missed on sales but met expectations for adjusted earnings this morning. GAAP earnings fell nearly 100% however, sparking a sell-off.

Why UnitedHealth Group Stock Just Crashed

UnitedHealth Group Incorporated (UNH) Q4 2025 Earnings Call Transcript

UnitedHealth Group (NYSE: UNH) crashed nearly 20% this morning after the insurance behemoth came in slightly ahead of estimates in its fiscal Q4 but issued disappointing guidance for 2026.

UnitedHealth stock falls despite earnings beat; CMS warns on buying dip

UnitedHealth Group Incorporated Q4 earnings and guidance disappointed, with both revenue and EPS missing internal expectations and consensus. UNH's medical care ratio remains elevated at 89.1%, signaling ongoing margin pressure despite some improvement from prior quarters. Medicare Advantage reimbursement rates are set to barely increase, compounding near-term headwinds and tempering the earnings outlook.

UnitedHealth Group: Double Whammy Disaster

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say

UnitedHealth Group Incorporated shares plunged over 15% after Q4 results, driven by a revenue miss and notably weak 2026 revenue guidance. UNH's 2025 profit guidance remains strong, with EPS expected to exceed $17.75, suggesting a margin improvement focus despite softer revenue growth. Recent margin compression stemmed from rising medical costs and Medicare funding cuts, but these headwinds were already anticipated and reflected in consensus.

UnitedHealth: Outlook Makes Shares Plunge

Over the past decade, UnitedHealth Group (NYSE: UNH) has leveraged its dominant position in the managed care and health services sectors to return $78 billion to shareholders, split between $26 billion in dividends and $52 billion in share repurchases.

How UNH Stock Returned $78 Billion To Shareholders

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares opened almost 17% lower at about $293 after the healthcare insurance firm issued weak guidance for 2026. The company expects revenue of more than $439 billion in 2026, implying a roughly 2% drop from the prior year.

UnitedHealth shares plunge on weak guidance, quarterly revenue miss

UnitedHealth Group Incorporated maintains a Buy rating despite recent sharp declines driven by weak guidance and regulatory headwinds. Q4 revenue missed by $520 million, with a conservative FY 2026 revenue guide of $439 billion, well below consensus. UNH stock valuation appears attractive near $300, with normalized EPS of $18 and a conservative 20x multiple suggesting upside to $360.

UnitedHealth: The Bearish 1-2 Punch Pressuring Shares, And Why I'm Bullish

UnitedHealth Group ( NYSE:UNH ) reported fourth-quarter and full-year 2025 earnings this morning that fell slightly short of analyst estimates, while offering guidance for the coming year that indicated a roughly 2% decline year-over-year due to its right-sizing efforts payment increase for Medicare Advantage plans in 2027 that was far below what was anticipated.

UnitedHealth Tanks on Medicare Rates Shock. Time to Sell the Insurance Giant?

UnitedHealth Group (NYSE: UNH) stock is already under pressure after the U.S. Centers for Medicare & Medicaid Services on Monday signalled essentially unchanged rates for Medicare insurers next year.

UnitedHealth's Revenue Outlook, Medicare Shock Spook Investors

UnitedHealth Group (UNH) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $6.81 per share a year ago.

UnitedHealth Group (UNH) Q4 Earnings Beat Estimates

UnitedHealth's stock tumbles, after a lower 2026 revenue outlook came along with disappointing Medicare Advantage rates announced by the Trump administration.

UnitedHealth's stock falls further after saying it expects revenue to decline in 2026

UnitedHealth Group reported fourth-quarter results and issued 2026 earnings guidance that were in line with lowered Wall Street expectations, as the company said it was making progress on its financial turnaround.

UnitedHealth Books Hefty Charges, Issues Soft Full-Year Revenue Outlook

UnitedHealth Group eked out a fourth quarter profit of $10 million despite a $1.6 billion hit to fourth quarter earnings from a large restructuring charge taken as the healthcare giant works on a financial turnaround.

UnitedHealth Takes $1.6 Billion Hit To Earnings Amid Restructuring

UnitedHealth on Tuesday forecast 2026 adjusted profit slightly above analysts' estimates, in a sign that medical cost-control measures under CEO Stephen Hemsley were beginning to reap results.

UnitedHealth forecasts 2026 profit slightly above estimates

UnitedHealth Group posted a modest fourth-quarter earnings beat, but issued soft revenue guidance for 2026. It comes as the parent company of the nation's largest private insurer, UnitedHealthcare, works to turn itself around while grappling with higher-than-expected medical costs.

UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today reported full year and fourth quarter 2025 results and issued its 2026 outlook. “We confronted challenges directly and finished 2025 as a much stronger company, giving us the momentum to better serve those who count on us and continue to improve our core performance,” said Stephen Hemsley, chief executive officer of UnitedHealth Group. Consolidated revenues for 2025 were $447.6 billion, representing 12% growth year-over-year. Earnings from.

UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook

UnitedHealth Group Incorporated (NYSE: UNH) will release earnings results for the fourth quarter, before the opening bell on Tuesday, Jan. 27.

UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

UnitedHealth Group reported a modest fourth-quarter earnings beat but foresee lower 2026 revenue. Despite challenges, the company anticipates a profit boost due to improved cost-control measures under CEO Stephen Hemsley, with a strong 2025 finish boosting momentum.

UnitedHealth earnings beat fourth-quarter estimates but warned revenue will decline, a split result that could shift near-term trader positioning.

UnitedHealth Earnings Beat, Revenue Outlook Soft

Ford Doug Field departure on April 15, 2026, accompanies a vehicle-development reshuffle and may shift investor focus to EV execution, costs, and flows.

Ford Doug Field Departure Amid Restructuring

Anthropic valuation drew non-binding VC bids as the firm posted rapid revenue growth and potential IPO plans that are reshaping investor positioning.

Anthropic Valuation Draws VC Offers

American Eagle Sydney Sweeney Campaign expands jean-shorts and donates proceeds, prompting management to lift sales outlook and drawing trader interest.

American Eagle Sydney Sweeney Campaign Boosts Sales Outlook

Live Nation antitrust verdict raises the prospect of Ticketmaster divestiture and other judicial remedies, creating legal risk that could reprice shares.

Live Nation Antitrust Verdict Signals Ticketmaster Breakup

SEC ends pattern day trader rule, switching to real-time, risk-based margin requirements to broaden retail intraday access and shift broker flows.

SEC Ends Pattern Day Trader Rule, Broadens Retail Access

Allbirds pivot to AI used a $50M convertible financing to acquire GPU capacity; traders will watch shareholder votes, conversion risk and liquidity.

UnitedHealth Earnings Beat, Revenue Outlook Soft

KEY TAKEAWAYS

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Fourth-Quarter Results and Charges

2026 Outlook and Medicare Advantage Rates

Related Articles

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Read other top news stories